Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

NuVasive Reline Cervical System

K-Number: K213654 · 2022-02-23

Decision Date2022-02-23
Product CodeNKG
Advisory CommitteeOR
DecisionSubstantially Equivalent

Device Summary

NuVasive Reline Cervical System is the device name listed in this FDA 510(k) record. The listed applicant is Nu Vasive, Incorporated. It received FDA 510(k) clearance on 2022-02-23 under 510(k) number K213654. The device is classified under product code NKG. It was reviewed by the OR advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the NuVasive Reline Cervical System?

NuVasive Reline Cervical System is a medical device that received FDA 510(k) clearance on 2022-02-23. The listed applicant is Nu Vasive, Incorporated. The 510(k) number is K213654.

When did NuVasive Reline Cervical System receive FDA 510(k) clearance?

NuVasive Reline Cervical System received FDA 510(k) clearance on 2022-02-23, under 510(k) number K213654.

Who is the listed applicant for NuVasive Reline Cervical System?

The FDA 510(k) record lists Nu Vasive, Incorporated as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for NuVasive Reline Cervical System?

The FDA product code for NuVasive Reline Cervical System is NKG.

Other records listing Nu Vasive, Incorporated as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

View all 79 devices →

Related Devices (Code: NKG)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.